+253.1%
ASTS vs THC
+1,017.9%
-764.8%
-91.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -5.8% | -2.1% | -3.7% | -5.4% |
| 7D | +14.2% | +0.1% | +14.1% | +14.3% |
| 30D | -26.7% | +7.5% | -34.2% | -27.7% |
| 3M | -53.6% | +7.5% | -61.1% | -54.3% |
| 6M | -52.7% | +46.4% | -99.2% | -56.5% |
| YTD | -52.5% | +44.4% | -96.9% | -56.4% |
| 1Y | -46.5% | +43.4% | -89.9% | -50.8% |
| 3Y | +700.5% | +433.3% | +267.2% | +471.1% |
| 5Y | +168.5% | +262.5% | -94.0% | +98.0% |
| All | +253.1% | +1,017.9% | -764.8% | +162.8% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling